Naimish Patel insider trades

Open-market stock purchases and sales by Naimish Patel, Director at AgomAb Therapeutics NV, from SEC Form 4 filings since May 28, 2024.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +53%.

Recent trades

DateStockTradeValue
Sep 11, 2026AGMB AgomAb Therapeutics NVBought (not open market)—
May 29, 2026CRSP CRISPR Therapeutics AGSold$211K
May 29, 2026CRSP CRISPR Therapeutics AGBought (not open market)—
May 28, 2026CRSP CRISPR Therapeutics AGBought (not open market)—
Mar 20, 2026CRSP CRISPR Therapeutics AGBought (not open market)—
Mar 20, 2026CRSP CRISPR Therapeutics AGBought (not open market)—
Mar 16, 2026CRSP CRISPR Therapeutics AGSold$152K
Mar 14, 2026CRSP CRISPR Therapeutics AGBought (not open market)—

Companies traded

  • AGMB AgomAb Therapeutics NV: other filings, last Sep 11, 2026
  • CRSP CRISPR Therapeutics AG: 1 buy, 3 sales, last May 29, 2026

Get free alerts when Naimish Patel files a new trade →